Preprint · OA
via OpenAlex
A Human Neuron Alzheimer’s Disease Model Reveals Barriers to Senolytic Translatability
Chaska C. Walton, Ellen Y. Wang, Suckwon Lee, Cynthia J. Siebrand, Nicholas J. Bergo, Julie Kay Andersen
bioRxiv (Cold Spring Harbor Laboratory) · 2025
Abstract
Abstract Therapeutic successes in mouse models of Alzheimer’s disease (AD) largely fail to translate into clinical trials, with experimental drugs rarely validated in human models before being administered to humans. To address this, we developed an accessible method for long-term culture of commercially available primary human neurons and astrocytes, along with an amyloid-beta 1-42 (Aβ)-based in vitro AD model. Using this system, we evaluated two senolytic regimens previously shown to be effective in AD mouse models—Navitoclax and Dasatinib plus Quercetin (DQ)—and the natural killer cell line NK92 for emerging immune-mediated senescent cell ablation therapies. NK92 cells preferentially—but not exclusively—targeted Aβ-treated neurons and astrocytes with senescent-like phenotypes. DQ demonstrated a safe profile for human neurons, but Navitoclax exhibited non-selective neurotoxicity. These findings highlight risks of Navitoclax and NK-based interventions and underscore the critical need for human-relevant models in the AD drug-development pipeline to improve safety and clinical translatability.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2025.01.28.635165
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Walton, C.C., Wang, E.Y., Lee, S., Siebrand, C.J., Bergo, N.J., & Andersen, J.K. (2025). A Human Neuron Alzheimer’s Disease Model Reveals Barriers to Senolytic Translatability. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2025.01.28.635165
Vancouver
Walton CC, Wang EY, Lee S, Siebrand CJ, Bergo NJ, Andersen JK. A Human Neuron Alzheimer’s Disease Model Reveals Barriers to Senolytic Translatability. bioRxiv (Cold Spring Harbor Laboratory). 2025. doi:10.1101/2025.01.28.635165.
BibTeX
@unpublished{chaska2025AHuman,
title = {A Human Neuron Alzheimer’s Disease Model Reveals Barriers to Senolytic Translatability},
author = {Chaska C. Walton and Ellen Y. Wang and Suckwon Lee and Cynthia J. Siebrand and Nicholas J. Bergo and Julie Kay Andersen},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2025},
doi = {10.1101/2025.01.28.635165},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s Research & Therapy 2025
Open access · CC-BY
A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability
PLoS ONE 2024
Open access · CC-BY
Osteoporosis induced by cellular senescence: A mathematical model
Aging Cell 2020
Open access · CC-BY
Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
Frontiers in Endocrinology 2026
Open access · CC-BY
Senescent immune cells, inflammaging, and bone loss: therapeutic potential and translational challenges of senolytics in osteoporosis
Frontiers in endocrinology 2026
Open access · OA
Senescent immune cells, inflammaging, and bone loss: therapeutic potential and translational challenges of senolytics in osteoporosis.
Nature Communications 2022
Open access · CC-BY